October 17, 2024 06:07 GMT
HEALTHCARE: Merck KgaA (MRKGR: Baa2/BBB+): Capital Markets Day
HEALTHCARE
- Cites robust global trends in all three business sectors
- Life science "back on course" guiding to 7%-9% (from 7%-10%) growth
- Healthcare guiding To "slight growth" with mid-single-digit long-term growth
- Electronics 5%-9% up from 3-6%
- M&A is a possibility
- Confirms guidance for fiscal 2024:
- Sales €20.7-€22.1 bn (organic +2%-+5%)
- EBITDA €5.8bn-€6.4bn (+4%-+10%)
44 words